1Cheng JW. Rosuvastatin in the management of hyperlipidemia[J]. Chin Ther,2004,26(9): 1368-87.
2Davidson M,Ma P,Stein EA,et al. Comparison of effects on lowdensty lipoprotein and cholesterol with rosuvastoin versus atorvatatin in patients with type Ⅱ a orⅡ b hypercholesterolemia[J]. J Am Cardiol, 2002,89(3):268-75.
3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：346
5Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量：117
9Ling MC, Ruddy TD, deKemp RA, et al. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease[J]. Am Heart J, 2005,149(6):1137.
10Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[J]. N Engl J Med, 2008,359(21):2195-2207.
